Skip to content
Publicly Available Published by De Gruyter April 13, 2018

Chronic pelvic pain – pain catastrophizing, pelvic pain and quality of life

  • Megan Sewell EMAIL logo , Leonid Churilov , Samantha Mooney , Tony Ma , Peter Maher and Sonia R. Grover

Abstract

Background and aims

Chronic pelvic pain (CPP) impacts significantly on the lives of women. Negative coping responses such as pain catastrophizing are thought to be significant in predicting both pain severity and outcome. The combined effect of the individual’s response to pain and its severity on their quality of life (QoL) has not been well studied in women with CPP. Aims were to determine the prevalence of pain catastrophizing in women with CPP and to examine the associations between pain catastrophizing and levels of dysmenorrhea, non-cyclical pelvic pain, dyspareunia, dysuria, dyschezia and QoL.

Methods

A cross-sectional study including women aged 18–50 years, referred to a tertiary gynecology outpatients department at an Australian women’s hospital in 2015. Participants completed questionnaires including: pain catastrophizing scale (PCS); pelvic pain levels in the prior 3 months; and the World Health Organisation Quality of life – Bref Questionnaire (WHOQoL-Bref). Statistical analysis was performed using STATA (StataCorp, USA Version13).

Results

Participants (n = 115) had a median age of 29.0 [interquartile range (IQR): 23.0–38.0] years. The Pain catastrophizing score revealed that 60/113 [95% confidence interval (CI): 48.6, 71.2] of participants had a clinically relevant total score ≥30. There were statistically significant positive correlations between pain catastrophizing scores and pelvic pain levels in all five pain categories studied, dysmenorrhea (ρ = 0.37, p = 0.0001), non-cyclical pelvic pain (ρ = 0.46, p<0.0001), dyspareunia (ρ = 0.32, p = 0.0008), dysuria (ρ = 0.32, p = 0.0005) and dyschezia (ρ = 0.38, p = 0.0012). Participants who reported maximal pain levels (5/5) had significantly higher median pain catastrophizing scores when compared to those who reported no pain (0/5) in all categories. Overall QoL was considered as “good” in 71/113 (95% CI: 60.1, 81.0) participants and “poor” in 42/113 (95% CI: 32.0, 53.0) participants. Comparison to Australian female norms revealed significantly lower QoL scores in the physical domain, across all ages, and in psychological domain for those aged <30 and 30–40 years. There was a significant association between increased catastrophizing scores and reduced odds of good QoL. An increase in PCS by one point is associated with a 6.3% decrease in the odds of good QoL [odds ratio (OR) per one-point increase: 0.94 (95% CI: 0.89, 0.98), p = 0.008].

Conclusions

Pain catastrophizing is prevalent at clinically relevant levels in women with CPP across all domains. It is associated with higher pain levels and decreased QoL.

Implications

There is potential for further studies to investigate the predictive nature of pain catastrophizing and management targeting catastrophizing to improve outcomes in women with CPP.

1 Introduction

Chronic pelvic pain (CPP) has a substantial negative effect on women, their lives and their communities. CPP is commonly described as continuous or intermittent pain in the lower abdomen, lasting for at least 6 months, and not exclusively related to the menstrual period or sexual intercourse [1]. Up to two thirds of women in the general population have been found to experience CPP, often without diagnosis and management [2]. This prevalence indicates the need for greater public education and clinical attention to CPP. Previous studies have reported significantly lower quality of life (QoL) levels in numerous categories including physical, emotional, pain and mental health, when comparing women with CPP to UK norms [3]. There is a strong association between CPP and distress, disability, poor general health, low satisfaction levels and substantial costs to health services [4, 5]. In Australia the direct health care costs of endometriosis (often considered the leading cause of CPP) is an estimated 6 billion AUD per annum [6]. Indirect costs such as loss of work productivity, loss of employment, disability and absenteeism are estimated to cost the US 760 million USD per annum [4, 7, 8]. Furthermore, CPP is the single most common indication for referral to women’s health services, accounting for 20% of all outpatient appointments and 40% of all gynecological diagnostic laparoscopies [9, 10].

Painful experiences are comprised of many dimensions including cognition, emotion, behavior and motivation that affect each individual differently [11, 12]. The pain experience is further influenced by biological, psychological and social factors [6]. A common psychological feature of pain is catastrophizing. Catastrophizing has been defined as an exaggerated negative mental set present during an actual or anticipated painful experience [12, 13]. The pain catastrophizing scale (PCS) developed in 1995, consists of a total catastrophizing score and three subscales: “rumination” about pain; “magnification” of the pain problem; and feelings of “helplessness” [14]. Since the development of the PCS, there has been growing evidence of the tendency to “catastrophize” during painful stimulation. Recent studies have associated catastrophizing with a variety of different types of pain. For example, the acute pain of venepuncture had a significant positive correlation with PCS scores [15]. In lower back pain, higher levels of pain catastrophizing were found to predict low back pain at follow up [16]. Furthermore, catastrophizing has been associated with increased pain intensity, heightened disability, illness behaviors such as longer hospital stays, post-operative pain, post-operative analgesic use and the prediction of pain and disability outcomes [12, 13, 17].

Increasing evidence suggests that CPP may be similar to other chronic pain conditions with the same psychological and contextual elements. As-Sanie et al. demonstrated that it is the presence of pelvic pain (regardless of the presence or absence of endometriosis) that predicts heightened peripheral pain sensitivity thresholds [18]. We therefore, have conducted a cross-sectional study to determine the levels of pain catastrophizing in women with CPP and to explore its association to pain levels and QoL. We hypothesized that women with higher reported pain levels will have an associated increased level of pain catastrophizing, and that higher levels of pain catastrophizing will be negatively associated with QoL.

2 Materials and methods

Following informed written consent and institutional ethics approval (Mercy Health, HREC), consecutive participants were recruited from a tertiary women’s hospital gynecology outpatient department between February 9th, 2015 and July 23rd, 2015. The gynecology department receives referrals for all areas of gynecology. Participants were included if aged between 18 and 50, with a referral of at least 6 months of pelvic pain, including dysmenorrhea, dyspareunia, non-cyclical pelvic pain, lower abdominal pain, dyschezia or dysuria. Women were excluded if they were actively trying to conceive or had a history of hysterectomy as their management was likely to be modified by these. It was accepted that given referral to gynecology outpatients had occurred, participants may or may not have had previous treatments for their pelvic pain. This study reports on a component of a larger ongoing CPP study. Of 141 eligible CPP patients (Fig. 1), 115 women participated, and 26 women did not. Reasons cited for not participating were: not interested (n = 9); unable to complete the questionnaire due to English literacy limitations (n = 9); non-receipt of questionnaire during or prior to their outpatient appointment (n = 8). The initial contact for 90/115 was in in the waiting room at their appointment. Of 25 participants who were mailed a questionnaire in advance of their appointment, 17 returned their postal questionnaire prior to their appointment and 8 were followed up in the waiting room at the time of appointment. Ninety-eight questionnaires were complete, ten questionnaires were missing a single answer, five questionnaires were missing up to four answers and two questionnaires were missing responses to the 13 PCS questions. The questionnaires with missing data were excluded from relevant correlations.

Figure 1: 
          Flow chart demonstrating recruitment in the study of pelvic pain, pain catastrophizing and quality of life at a tertiary women’s hospital in 2015.
Figure 1:

Flow chart demonstrating recruitment in the study of pelvic pain, pain catastrophizing and quality of life at a tertiary women’s hospital in 2015.

2.1 Outcome measures

The questionnaires included in the study were: 1) The pain catastrophizing scale (PCS); 2) 6-point Likert scale for pain; 3) The World Health Organisation Quality of Life – Bref (WHOQoL – Bref) Questionnaire. The PCS is a validated scale with 13 items, each scored from 0 (not at all) to 4 (all the time) with a total score range of 0–52, across three domains: rumination (0–16); magnifications (0–12); and helplessness (0–24) [14]. The University Centre for Research on Pain and Disability indicates that a total PCS score of ≥30 is clinically relevant [13]. Pain levels were reported using a six-point Likert rating scale (0–5) where 0 indicated no painful symptoms and five indicated the worst pain imaginable. This rating scale was used to assess pain with menses (dysmenorrhea), non-cyclical pain (pelvic pain), pain with micturition (dysuria), with defecation (dyschezia), and with sexual intercourse (dyspareunia). Participants were asked to rate their “average” pain level over the previous 3 months. A 3 month duration was requested given the often cyclical nature of pelvic pain, especially dysmenorrhoea, and thus ensure a minimum of two menstrual cycles were considered when participants were providing responses. The WHOQoL-Bref is a validated and shortened 26-question version of the WHOQoL-100 assessment instrument [19]. There are four main domains of QoL assessed: physical (7–35); psychological (6–30); social (3–15); and environmental (8–40); as well as overall QoL (1–5) and general health (1–5). The questions are formulated in a Likert response scale, with intensity, capacity, frequency and overall quality and satisfaction examined. For the purpose of this study, responses were grouped to reflect the general clinical context, with “good” QoL defined as those rating their QoL as “good” or “very good”, and “poor” QoL defined as those rating their QoL as “very poor”, “poor” or “neither poor nor good”. Participants were also asked to provide an obstetric history (including mode of delivery for each child) and to list any previous or current treatment regimens for their CPP, including surgical interventions, as well as any previous abdominal procedures.

2.2 Statistics

The statistical analysis was performed using the STATA Data Analysis and Statistical Software (STATACorp, TX, USA, Version 13). A p-value <0.05 was considered statistically significant for all comparisons, with no correction for multiple comparisons. The confidence intervals (CI) reported are all 95% intervals. An association between reported pain levels and PCS scores was estimated using Spearman’s correlation coefficient. A median bootstrap regression was performed to estimate the magnitudes of difference between PCS scores for various pain levels. A logistic regression model was used to investigate the association between the QoL and PCS scores adjusted for age and reported pain levels. The effects are summarized as adjusted odds ratios (with corresponding 95% confidence intervals) of good (dichotomized) or increased (ordinal) overall QoL with an increase of PCS total score by one point. Lastly, a comparison of mean WHOQoL-Bref scores and confidence intervals between the study population and a study of Australian women was performed. The population of the comparison study was a stratified sample of residents from Victoria, Australia covering a broad range of health conditions from full health to terminal illness [20].

3 Results

Participants (n = 115) were between 18 and 50 years, with a median age of 29.0 years [interquartile range (IQR): 23.0–38.0]. Study participants were younger than non-participants [median age of 35.0 years (IQR: 28.0–41.0)]. Of the 107 women who responded to the parity questions, 53 women had been pregnant (average of 2.7 times) and 48 had a child (average two children). Seventy-five participants stated that they were currently receiving treatment, analgesia or hormonal therapies, for their pelvic pain. Seventy-five women stated they had previously had treatment for their pelvic pain, including some of the women currently receiving treatment. Fifty-four women had previously had abdominal surgery.

3.1 Pain catastrophizing scale (PCS)

The PCS total score and subscales (rumination, magnification, helplessness) are summarized in Table 1. The PCS scores revealed that 60/113 (CI: 48–71) participants had a clinically relevant level of catastrophizing (PCS total ≥30). The median value was 30 (IQR: 21–39).

Table 1:

Pain Catastrophizing Scale, total and subscale scores from 115 women referred to a tertiary women’s hospital in Australia in 2015.

Subscales (range) Median Interquartile range (IQR)
Total (0–52) 30 21–39
Rumination (0–16) 10 6–14
Magnification (0–12) 6 4–9
Helplessness (0–24) 14 8–18

3.2 Pelvic pain levels

All participants reported experiencing either or both dysmenorrhea 106/113 (CI: 99, 110) and non-cyclical pelvic pain 101/115 (CI: 90, 107). Dyspareunia was reported by 78/105 (CI: 68, 86) women, dysuria 69/115 (CI: 57, 79) and dyschezia 84/115 (CI: 73, 93). Participants reported median pain levels of 4 for dysmenorrhea, 4 for non-cyclical pelvic pain, 2 for dyspareunia, 1 for dysuria, and 3 for dyschezia (range: 0–5).

Seven participants reported having no dysmenorrhea and two reported having amenorrhea, one due to a levonorgestrel intrauterine system (LNG IUS) and the other following an endometrial ablation. Almost two thirds of the women experiencing dysmenorrhea (n = 106), reported a pain level of either 4/5 or 5/5 (42 and 25, respectively). Over half of the women experiencing non-cyclical pelvic pain (n = 101) reported a 4/5 or 5/5 pain level (33 and 25, respectively). Twenty-seven women did not experience dyspareunia and a further ten women had not been sexually active in the last 3 months. Of the remaining women (n = 78), 28 reported a 4/5 or 5/5 pain level with sexual intercourse (17 and 11, respectively), and of the 69 experiencing dysuria, 21 reported a pain level of 4/5 or 5/5 (16 and 5, respectively). Of the women experiencing dyschezia (n = 84), 30 reported a 4/5 or 5/5 pain level (18 and 12, respectively).

There was a significant positive correlation between all five pelvic pain categories and the PCS total score as follows (Table 2): dysmenorrhea (Spearman’s ρ = 0.369, p = 0.0001); non-cyclical pelvic pain (Spearman’s ρ = 0.460, p<0.0001); dyspareunia (Spearman’s ρ = 0.323, p = 0.0008); dysuria (Spearman’s ρ = 0.323, p = 0.0005); and dyschezia (Spearman’s ρ = 0.367, p = 0.0012). A median difference in PCS scores (estimated by bootstrapped median regression) between women who reported no pain and those who reported “worst imaginable” pain varied between the pain categories as follows: dysmenorrhea – median difference 18 points (CI: 1.5, 34.5, p = 0.03); non-cyclical pelvic pain – 17 points (CI: 7.52, 26.5, p = 0.001); dyspareunia – 17.5 points (CI: 6.3, 27.7, p = 0.002); dysuria – 17 points (CI: 4.9, 29.1, p = 0.006); and dyschezia – 17 points (CI: 4.7, 21.3, p = 0.003). The difference was statistically significant for all pain categories. There was also significant difference in median PCS scores between those who reported no pain and those who reported the following pain scores in each category: 4/5 in non-cyclical pelvic pain – 11 point difference (CI: 1.7, 20.3, p = 0.020); dysuria – 15 point difference (CI: 7.9, 22.1, p<0.001); and dyspareunia – 8 point difference (CI: 0.9, 15.9, p = 0.048); 3/5 for dyschezia – 8 point difference (CI: 0.4, 15.6, p = 0.040); and 1/5 for dysmenorrhea – 18 point difference (CI: 1.0, 35.0, p = 0.034).

Table 2:

Pelvic pain levels in each category and their corresponding catastrophizing scores reported from 115 women referred to a tertiary women’s hospital in Australia (2015).

Pain components Pain score n PCS: median, IQR Bootstrapped median regression p-value
Dysmenorrhea (n = 113) 0 7 19.0, 4.0–29.0 Reference
Median = 4 1 2 36.5, 36.0–37.0 0.038a
(Spearman ρ = 0.369, p = 0.0001) 2 8 25.5, 14.0–38.5 0.382
3 29 23.0, 15.0–30.0 0.554
4 42 32.5, 24.0–39.0 0.148
5 25 37.5, 29.0–42.5 0.033a
Non-cyclical pelvic pain (n = 115) 0 14 21.5, 15.0–34.0 Reference
Median = 4 1 11 23.5, 13.0–31.0 0.879
(Spearman ρ = 0.460, p<0.0001) 2 6 14.0, 7.0–26.0 0.360
3 26 25.5, 18.0–32.0 0.390
4 33 34.0, 29.5–39.0 0.020a
5 25 39.0, 29.0–44.0 0.001a
Dyspareunia (n = 105) 0 27 24.5, 21.0–30.0 Reference
Median = 2 1 11 18.0, 12.0–29.0 0.234
(Spearman ρ = 0.323, p = 0.0008) 2 15 34.0, 19.0–43.0 0.058
3 24 32.5, 17.0–38.0 0.059
4 17 33.0, 27.0–43.0 0.048a
5 11 42.0, 26.0–44.0 0.002a
Dysuria (n = 115) 0 46 25.0, 20.0–32.0 Reference
Median = 1 1 22 33.0, 16.0–39.0 0.160
(Spearman ρ = 0.323, p = 0.0005) 2 15 29.0, 10.0–38.0 0.381
3 11 33.0, 18.0–44.0 0.174
4 16 40.5, 27.5–44.5 0.000a
5 5 42.0, 33.0–46.0 0.006a
Dyschezia (m = 115) 0 31 24.0, 17.0–31.0 Reference
Median = 3 1 14 25.5, 21.0–38.0 0.708
(Spearman ρ = 0.367, p = 0.0012) 2 12 27.0, 13.5–37.0 0.881
3 28 33.0, 25.5–42.5 0.040a
4 18 30.0, 16.0–41.0 0.324
5 12 41.0, 37.0–45.0 0.003a
  1. aBootstrap regression (p<0.05). Significance of the difference in the median PCS scores of the given pain level and the pain level of zero.

3.3 Quality of life (QoL)

Overall perception of QoL was considered as good by 71/113 (CI: 60.1, 81.0) and poor in 42/113 (CI: 32.0, 53.0) of participants. Table 3 demonstrates a comparison between the study participants and Australian female norms across the four domains of QoL: physical health; physiological; social relationship; and environment. The study population reported significantly lower QoL scores in the physical domain across all age groups, and in psychological domain for the age groups <30, and between ages 30 and 40. In all other comparisons between the study population and Australian female norms, participants had lower QoL scores, but failed to demonstrate statistical significance. Of the participants who perceived their overall QoL to be good (n = 71), 44/71 had a total PCS <30, 26/71 had a total PCS score >30 and 1/71 did not complete their PCS questionnaire. Of participants who perceived their overall QoL to be poor (n = 42), 9/42 had a total PCS <30, 32/42 had a total PCS >30, and 1/42 did not complete their PCS questionnaire. Based on the logistic regression modeling, in women with similar age and reported pain levels, an increase in PCS total score by one point is associated with a 6.3% decrease in odds of experiencing “good” QoL [adjusted OR = 0.94, (CI: 0.89–0.98), p = 0.008]. The results were qualitatively similar without adjustments for age or pain levels, with an 8% associated decrease in the odds of good QoL [OR = 0.92, (CI: 0.88–0.96), p<0.001]. When analyzed across the full ordinal scale, an increase of PCS by one point is associated with a 4.2% decrease in odds of better QoL [adjusted OR = 0.96, (CI: 0.92–0.99), p = 0.023].

Table 3:

WHOQoL – Bref scores from 115 women referred to a tertiary women’s hospital in Australia in 2015 and Australian female norms [20].

Age bracket <30 years old 30–40 years old 40–50 years old
Physical domain (mean, CI) Study 52.3, 46.6–57.9 54.5, 46.8–62.4 50.0, 40.0–59.9
Aust. norms 83.6, 79.4–87.8 80.3, 76.4–84.2 77.5, 70.5–84.5
Psychological domain (mean, CI) Study 52.6, 47.7–57.5 55.9, 48.0–63.8 61.1, 51.9–70.4
Aust. norms 69.7, 63.0–76.4 73.6, 70.2–77.0 71.1, 66.3–75.9
Social domain (mean, CI) Study 66.5, 62.2–70.8 61.5, 52.4–70.7 66.9, 56.8–77.0
Aust. norms 75.6, 69.9–81.3 74.8, 69.1–80.15 76.8, 71.3–82.3
Environmental domain (mean, CI) Study 69.5, 65.5–73.6 69.1, 63.7–74.5 68.8, 61.9–75.7
Aust. norms 72.7, 66.9–78.5 73.4, 69.8–77.0 72.7, 68.2–77.2
  1. Bold and Italic: 95% confidence intervals do not overlap.

4 Discussion

This study demonstrates the relationship between pain catastrophizing, pelvic pain levels and QoL in women with CPP. A PCS score of 30 corresponds to the 75th percentile in the distribution of clinical samples of chronic pain patients and has been deemed a clinically relevant “cutoff” by the University Centre for Research on Pain and Disability [13]. Previous studies of patients with soft tissue back injuries found that 70% of those who scored ≥30 on the PCS remained unemployed, 70% reported occupational disability and 66% were found to have moderate depression on the Beck Depression Inventory-II [13]. Our results illustrate comparable or higher pain catastrophizing levels in the CPP population than in other chronic pain conditions, with 60/113 participants (53%, CI: 43%–63%) having a PCS score ≥30. Previous studies have demonstrated that PCS scores between 20 and 30 are considered to be at moderate risk of developing pain chronicity, and above 30 as high risk [13]. Many studies have also used PCS or similar scales as a prediction tool for disability, pain continuation, pain outcomes, and illness behaviors such as longer hospital stays, post operative pain, post operative analgesic use, frequency of visits to health care professionals and increased use of over the counter medications [12, 17, 21]. Our findings suggest over half of the study population may be at high risk for continued chronicity of their pain with the potential risk of associated disability, unemployment and depression. This emphasizes the importance of practitioners to consider and address catastrophizing and broader psychosocial components of pain within the CPP population, including psychological support.

Associations between pain catastrophizing and heightened pain experience have been demonstrated across various pain conditions and procedures [12]. This is supported by our results of significant associations between all five pelvic pain categories and PCS scores (Table 2). The strongest correlations were demonstrated in non-cyclical pelvic pain and dysmenorrhea. These were also the two most commonly reported painful symptoms, emphasizing the prevalence and importance of catastrophizing within this cohort. Interestingly, when analysing pain levels associated with dyspareunia we found those who scored either 2/5 or 3/5 had PCS scores substantially higher than those who scored no pain, suggesting a negative coping response, as measured by the PCS, impacts at lower levels of pain scores for dyspareunia when compared to other pelvic pain categories. Previous studies have demonstrated high pain catastrophizing levels are associated with increased pain ratings and a negative impact on the experience of intercourse [11]. The higher pain catastrophizing scores at lower pain levels could be explained by increased anxiety and psychosocial implications associated with dyspareunia and sexual intercourse. In Desrochers et al. [22] study of women with superficial dyspareunia (vestibulodynia and vulvodynia), a multiple linear regression analysis established the relative contribution of validated psychological variables including catastrophizing (PCS), pain related fear, hypervigilance and self-efficacy. The total regression of all variables significantly contributed to a 15% variance in pain for the subjects [22]. However, only PCS contributed an individual variance to the prediction of dyspareunia (p = 0.046), illustrating that whilst depression, anxiety, fear of pain and hyper-vigilance are all psychological variables of dyspareunia, they contribute less than catastrophizing to pain intensity, predictions of disability, pain maintenance and chronicity of dyspareunia [11, 22].

Numerous studies have examined QoL of those suffering from CPP [4, 23, 24, 25]. Our findings of significantly lower QoL levels in the physical domain across all ages and in the psychological domain for the ages <30 and between 30 and 40 in comparison to Australian norms, support previous research. The relationship between QoL and catastrophizing is often looked at specifically in terms of treatment outcomes, and psychosocial factors. In this study, a broad QoL scale demonstrated that catastrophizing plays a role in decreasing overall QoL, illustrating the significance of catastrophizing in the experience of chronic pain and negative impact on daily life. It is difficult to delineate whether decreased QoL, secondary to pain intensity occurs first, and then results in increased pain catastrophizing. Nevertheless, the association warrants recognition in the clinical context.

Limitations of this study include reduced statistical power with a total of 115 participants, however we deemed the clinical findings and correlations sufficient to draw meaningful conclusions. The cross-sectional nature of this study is also a limitation, though it is a direct reflection of information gathering in an outpatient clinical context. As with many self-report and pain experience analyses, the subjective responses to catastrophizing, pain levels and QoL may be skewed by individual perception and experience. We view this as a reflection of the overall painful experience and sought to utilize validated questionnaires to produce accurate data. As the questions required retrospective responses, there is a potential recall bias, though this mirrors information gathering in a clinical outpatient consultation scenario. Despite parity and previous history of medical and surgical treatment influencing pain levels, all participants, regardless of previous history, were included as a single cohort, to best represent a true general gynecological outpatient population for analysis and findings. Finally, there is a potential selection bias, demonstrated by the difference in age between eligible participants who did, and did not, participate in the study. Participants’ median age was 29.0 years (IQR: 23.0–38.0) and non-participants median age was 35.0 (IQR: 28.0–41.0).

In conclusion, the perception of pain and its psychological factors varies from one individual to another. Research has shown catastrophizing to be a powerful marker for heightened pain experience. In a condition as common as CPP, it is crucial for the practitioner to consider the strong associations between pain catastrophizing, pelvic pain and QoL. Psychological domains should be of great importance to clinicians caring for women with CPP, and the possibility of catastrophizing playing a role in prediction of pain outcomes in these women warrants further assessment. Further investigation is needed to determine whether pain catastrophizing can be used as a predictor of outcomes in CPP, as has been done in research of other chronic pain conditions. We postulate that it may be possible to aid patients with higher PCS scores by implementing psychological supports and predicting post treatment pain outcomes, thus allowing for better treatment choices and planning.

Acknowledgements

We wish to express our gratitude and thanks to Mrs Jennifer Porter, and the Mercy Hospital for Women’s Gynaecology Units; Plenty Gynaecology and Endosurgery A.

  1. Authors’ statements

  2. Research funding: Financial support by The Norman Beischer Medical Research Foundation.

  3. Conflict of interest: The authors report no conflict of interest.

  4. Informed consent: Informed written consent was received from every participant.

  5. Ethical approval: Ethics was approved by Mercy Health, HREC.

References

[1] Grace VM, Zondervan KT. Chronic pelvic pain in New Zealand: prevalence, pain severity, diagnoses and the use of the health services. Aus N Z J Public Health 2004;28:369–75.10.1111/j.1467-842X.2004.tb00446.xSearch in Google Scholar

[2] Williams R, Hartmann K, Steege JF. Documenting the current definitions of chronic pelvic pain: implications for research. Obstet Gynecol 2004;103:686–91.10.1097/01.AOG.0000115513.92318.b7Search in Google Scholar PubMed

[3] Cox L, Ayers S, Mala K, Penny J. Chronic pelvic pain and quality of life after laparoscopy. Eur J Obstet Gynecol Reprod Biol 2007;132:214–9.10.1016/j.ejogrb.2006.04.020Search in Google Scholar PubMed

[4] Mathias SD, Kuppermann M, Liberman RF, Lipshutz RC, Steege JF. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol 1996;87:321–7.10.1016/0029-7844(95)00458-0Search in Google Scholar PubMed

[5] Fagervold B, Jenssen M, Hummelshoj L, Moen MH. Life after a diagnosis with endometriosis – a 15 years follow-up study. Acta Obstet Gynecol Scand 2009;88:914–9.10.1080/00016340903108308Search in Google Scholar PubMed

[6] Bush D, Evans S, Vancaillie T. The Pelvic Pain Report: the $6 Billion Woman and the $600 Million Girl. Pain Australia, Faculty of Pain Medicine ANZCA. 2011:1–74.Search in Google Scholar

[7] Howard FM. Chronic pelvic pain. Obstet Gynecol 2003;101: 594–611.10.1016/S0029-7844(02)02723-0Search in Google Scholar PubMed

[8] Yunker A, Sathe NA, Reynolds WS, Likis FE, Andrews J. Systematic review of therapies for noncyclic chronic pelvic pain in women. Obstet Gynecol Surv 2012;67:417–25.10.1097/OGX.0b013e31825cecb3Search in Google Scholar PubMed

[9] Howard FM. Laparoscopic evaluation and treatment of women with chronic pelvic pain. J Am Assoc Gynecol Laparosc 1994;1:325–31.10.1016/S1074-3804(05)80797-2Search in Google Scholar

[10] Latthe P, Latthe M, Say L, Gulmezoglu M, Khan KS. WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health 2006;6:177.10.1186/1471-2458-6-177Search in Google Scholar PubMed PubMed Central

[11] Thomten J, Linton SJ. A psychological view of sexual pain among women: applying the fear-avoidance model. Women’s Health (Lond) 2013;9:251–63.10.2217/WHE.13.19Search in Google Scholar

[12] Sullivan MJ, Thorn B, Haythornthwaite JA, Keefe F, Martin M, Bradley LA, Lefebvre JC. Theoretical perspectives on the relation between catastrophizing and pain. Clin J Pain 2001;17:52–64.10.1097/00002508-200103000-00008Search in Google Scholar PubMed

[13] Sullivan M. The Pain Catastrophizing Scale; User Manual. 2009.Search in Google Scholar

[14] Sullivan M, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess 1995;7:524–32.10.1037//1040-3590.7.4.524Search in Google Scholar

[15] Suren M, Kaya Z, Gokbakan M, Okan I, Arici S, Karaman S, Comlekci M, Balta MG, Dogru S. The role of pain catastrophizing score in the prediction of venipuncture pain severity. Pain Pract 2014;14:245–51.10.1111/papr.12060Search in Google Scholar PubMed

[16] Picavet HS, Vlaeyen JW, Schouten JS. Pain catastrophizing and kinesiophobia: predictors of chronic low back pain. Am J Epidemiol 2002;156:1028–34.10.1093/aje/kwf136Search in Google Scholar PubMed

[17] Martin CE, Johnson E, Wechter ME, Leserman J, Zolnoun DA. Catastrophizing: a predictor of persistent pain among women with endometriosis at 1 year. Hum Reprod 2011;26:3078–84.10.1093/humrep/der292Search in Google Scholar PubMed PubMed Central

[18] As-Sanie S, Harris RE, Napadow V, Kim J, Neshewat G, Kairys A, Williams D, Clauw DJ. Schmidt-Wilcke T. Increased pressure pain sensitivity in women with chronic pelvic pain. Obstet Gynecol 2013;122:1047–55.10.1097/AOG.0b013e3182a7e1f5Search in Google Scholar PubMed PubMed Central

[19] The WHOQOLGroup, Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. Psychol Med 1998;28:551–8.10.1017/S0033291798006667Search in Google Scholar PubMed

[20] Hawthorne G, Herman H, Murphy B. Interpreting the WHOQOL-Brèf: preliminary population norms and effect sizes. Soc Indic Res 2006;77:37–59.10.1007/s11205-005-5552-1Search in Google Scholar

[21] Roth ML, Tripp DA, Harrison MH, Sullivan M, Carson P. Demographic and psychosocial predictors of acute perioperative pain for total knee arthroplasty. Pain Res Manag 2007;12:185–94.10.1155/2007/394960Search in Google Scholar PubMed PubMed Central

[22] Desrochers G, Bergeron S, Khalife S, Dupuis MJ, Jodoin M. Fear avoidance and self-efficacy in relation to pain and sexual impairment in women with provoked vestibulodynia. Clin J Pain 2009;25:520–7.10.1097/AJP.0b013e31819976e3Search in Google Scholar PubMed

[23] Laursen BS, Bajaj P, Olesen AS, Delmar C, Arendt-Nielsen L. Health related quality of life and quantitative pain measurement in females with chronic non-malignant pain. Eur J Pain 2005;9:267–75.10.1016/j.ejpain.2004.07.003Search in Google Scholar PubMed

[24] Jones GL, Kennedy SH, Jenkinson C. Health-related quality of life measurement in women with common benign gynecologic conditions: a systematic review. Am J Obstet Gynecol 2002;187:501–11.10.1067/mob.2002.124940Search in Google Scholar PubMed

[25] Tripoli TM, Sato H, Sartori MG, de Araujo FF, Girao MJ, Schor E. Evaluation of quality of life and sexual satisfaction in women suffering from chronic pelvic pain with or without endometriosis. J Sex Med 2011;8:497–503.10.1111/j.1743-6109.2010.01976.xSearch in Google Scholar PubMed


Article note

Research was presented at the Australian Pain Society 36th Annual Scientific Meeting in March 2016.


Received: 2017-12-10
Revised: 2018-03-16
Accepted: 2018-03-18
Published Online: 2018-04-13
Published in Print: 2018-07-26

©2018 Scandinavian Association for the Study of Pain. Published by Walter de Gruyter GmbH, Berlin/Boston. All rights reserved

Downloaded on 25.4.2024 from https://www.degruyter.com/document/doi/10.1515/sjpain-2017-0181/html
Scroll to top button